Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
Clinical trial NCT05673057 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05673057
- Sponsor
- Molecular Partners AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-29
- Primary completion
- 2026-05-29
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.